Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

European Stock Futures Higher; Fed Meeting Looms Large

Published 09/21/2021, 02:00 AM
Updated 09/21/2021, 02:03 AM
© Reuters.

By Peter Nurse 

Investing.com - European stock markets are expected to open higher Tuesday, rebounding from the previous session’s sharp losses, although worries remain about the contagion risks associated with property giant China Evergrande Group, while the Federal Reserve's policy meeting continues to dominate thinking.

At 2:05 AM ET (0605 GMT), the DAX futures contract in Germany traded 0.4% higher, CAC 40 futures in France climbed 0.2% and the FTSE 100 futures contract in the U.K. rose 0.5%.

European equities sold off heavily on Monday, with the DAX ending 2.3% lower and the CAC 40 down 1.7%, sparked by concerns of a disorderly default in China, potentially hurting China's property and financial sectors at a time when growth in the world's second-largest economy is already slowing.

Evergrande has an $83.5 million interest payment for its March 2022 bond due on Thursday and a second $47.5 million interest payment due on Sep. 29 for its March 2024 notes. It has already missed a small payment to bank creditors.

However, the main focus Tuesday will be on the Federal Reserve, with the U.S. central bank starting its two-day meeting. Most expect the Fed to give a strong signal that it will start running down its bond purchases before year end, while there is more doubt about whether the central bank's so-called 'dot plot' will shift to reflect expectations of earlier rate hikes.

Back in Europe, the auto sector will be in focus after German newspaper Handelsblatt reported that an environmental NGO has sued BMW (DE:BMWG) and Daimler (OTC:DDAIF) for refusing to tighten their carbon emissions targets and give up fossil fuel-emitting cars by 2030.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Also of note, Swiss drugmaker Novartis (SIX:NOVN) announced Tuesday that it has bought gene therapy specialist Arctos Medical to boost its efforts finding treatments for patients with severe vision loss.

Crude prices also rebounded Tuesday, advancing after days of losses after indications that disruptions to crude output in the U.S. Gulf of Mexico will last into next year.

Royal Dutch Shell (LON:RDSa), the biggest oil producer in the region, said Monday that production from two of its largest fields there will not resume until 2022 given the damage caused by Hurricane Ida in late August.

Investors will now focus on crude oil supply data from the American Petroleum Institute later in the session for more information.

By 2:05 AM ET, U.S. crude futures traded 1% higher at $70.83 a barrel, while the Brent contract rose 0.9% to $74.57. Both contracts slumped around 2% last session.

Additionally, gold futures traded flat at $1,763.75/oz, while EUR/USD traded 0.1% higher at 1.1733.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.